An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 315 participants.
Also called NCT01078675
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 315 participants
- Sponsor
- Registry
-
NCT01078675
-
- Other papers using this trial's data
- Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH children
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belgium, Canada, Netherlands, Norway
- Registry status
- Completed
Technical summary
Registry record NCT01078675. Non-randomized; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2013-02 (actual). Results posted on 2015-02-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia
- Condition
- Familial Hypercholesterolaemia
- Intervention (Drug)
- rosuvastatin calcium
- Intervention (Drug)
- rosuvastatin calcium
- Intervention (Drug)
- rosuvastatin calcium
- Lead sponsor
- AstraZeneca
Record details
- Record id
cardio:ct-nct01078675- Content hash
c17955f7f3fb6cb3471fe5cda8d82611ba664649a681b8119b537394dda8ecfd